135 related articles for article (PubMed ID: 26525480)
1. [The new possibility for the treatment of acute cough].
Klyachkina IL
Vestn Otorinolaringol; 2015; 80(5):85-90. PubMed ID: 26525480
[TBL] [Abstract][Full Text] [Related]
2. [Novel approach to respiratory pharmacology--pharmacological basis of cough, sputum and airway clearance].
Miyata T
Yakugaku Zasshi; 2003 Dec; 123(12):987-1006. PubMed ID: 14689863
[TBL] [Abstract][Full Text] [Related]
3. Effect of a single 1200 Mg dose of Mucinex® on mucociliary and cough clearance during an acute respiratory tract infection.
Bennett WD; Kala A; Duckworth H; Zeman KL; Wu J; Henderson A; Yopp M; Rubin BK
Respir Med; 2015 Nov; 109(11):1476-83. PubMed ID: 26462765
[TBL] [Abstract][Full Text] [Related]
4. Mucoactive agents for airway mucus hypersecretory diseases.
Rogers DF
Respir Care; 2007 Sep; 52(9):1176-93; discussion 1193-7. PubMed ID: 17716385
[TBL] [Abstract][Full Text] [Related]
5. [Therapeutic modalities for the management of cough associated with acute respiratory viral infection, effective in an otolaryngologist's practice].
Ovchinnikov AI; Paniakina MA; Korostelev SA; Mitiuk AM
Vestn Otorinolaringol; 2014; (2):86-9. PubMed ID: 24781181
[TBL] [Abstract][Full Text] [Related]
6. [Rengalin, a novel drug for treatment of cough in children. Intermediate data on multicentre, comparative randomized clinical trial].
Geppe NA; Kondyurina EG; Galustyan AN; Pak TE; Baltserovich NB; Zhiglinskaya OV; Kamaev AV; Lazareva SG; Laleko SL; Melnikova IM; Mikhalkova EV; Perminova OA; Sabitov AU; Spivakovsky YM
Antibiot Khimioter; 2014; 59(7-8):16-24. PubMed ID: 25975103
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the efficacy and safety of a combination drug containing ambroxol, guaifenesin, and levosalbutamol versus a fixed-dose combination of bromhexine/guaifenesin/salbutamol in the treatment of productive cough in adult patients with acute bronchitis].
Zaitsev AA; Leshchenko IV; Esaulova NA; Viktorova IA
Ter Arkh; 2023 Apr; 95(3):236-242. PubMed ID: 37167145
[TBL] [Abstract][Full Text] [Related]
8. Eosinophilic airway inflammation is common in subacute cough following acute upper respiratory tract infection.
Lai K; Lin L; Liu B; Chen R; Tang Y; Luo W; Chen Q
Respirology; 2016 May; 21(4):683-8. PubMed ID: 26969485
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of myrtol standardized in acute bronchitis. A multi-centre, randomised, double-blind, placebo-controlled parallel group clinical trial vs. cefuroxime and ambroxol.
Matthys H; de Mey C; Carls C; Ryś A; Geib A; Wittig T
Arzneimittelforschung; 2000 Aug; 50(8):700-11. PubMed ID: 10994153
[TBL] [Abstract][Full Text] [Related]
10. Safety and usage pattern of an over-the-counter ambroxol cough syrup: a community pharmacy-based cohort study.
Schulz M; Hämmerlein A; Hinkel U; Weis G; Gillissen A
Int J Clin Pharmacol Ther; 2006 Sep; 44(9):409-21. PubMed ID: 16995329
[TBL] [Abstract][Full Text] [Related]
11. Ambroxol plus amoxicillin in the treatment of exacerbations of chronic bronchitis.
Peralta J; Poderoso JJ; Corazza C; Fernández M; Guerreiro RB; Wiemeyer JC
Arzneimittelforschung; 1987 Aug; 37(8):969-71. PubMed ID: 3675696
[TBL] [Abstract][Full Text] [Related]
12. Ambroxol in the 21st century: pharmacological and clinical update.
Malerba M; Ragnoli B
Expert Opin Drug Metab Toxicol; 2008 Aug; 4(8):1119-29. PubMed ID: 18680446
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of cough in acute respiratory virus infections and influenza by the patients of risk group].
Kliachkina IL
Voen Med Zh; 2009 Jul; 330(7):40-5. PubMed ID: 19827667
[TBL] [Abstract][Full Text] [Related]
14. [Rengalin, a New Efficacious and Safe Antitussive Agent. Results of a Randomized, Comparative, Multicenter Clinical Trial in Patients with Acute Respiratory Tract Infections].
Akopov AL; Aleksandrova EB; Il'kovich MM; Petrov DV; Trofimov VI
Antibiot Khimioter; 2015; 60(1-2):19-26. PubMed ID: 26168681
[TBL] [Abstract][Full Text] [Related]
15. Guaifenesin has no effect on sputum volume or sputum properties in adolescents and adults with acute respiratory tract infections.
Hoffer-Schaefer A; Rozycki HJ; Yopp MA; Rubin BK
Respir Care; 2014 May; 59(5):631-6. PubMed ID: 24003241
[TBL] [Abstract][Full Text] [Related]
16. [Eosinophilic bronchitis without asthma--an additional rare cause for chronic persistent cough (CPC)? A 30-year old patient with severe CPC due to eosinophilic bronchitis without asthma or hyperreactivity].
Kardos P
Pneumologie; 2001 May; 55(5):249-52. PubMed ID: 11449611
[TBL] [Abstract][Full Text] [Related]
17. [Value of ambroxol in treatment of bronchial asthma and spastic bronchitis].
Siergiejko Z; Obrzut D; Rogalewska A
Pol Tyg Lek; 1991 May 27-Jun 3; 46(22-23):424-7. PubMed ID: 1669082
[TBL] [Abstract][Full Text] [Related]
18. Ambroxol inhalation ameliorates LPS-induced airway inflammation and mucus secretion through the extracellular signal-regulated kinase 1/2 signaling pathway.
Zhang SJ; Jiang JX; Ren QQ; Jia YL; Shen J; Shen HJ; Lin XX; Lu H; Xie QM
Eur J Pharmacol; 2016 Mar; 775():138-48. PubMed ID: 26872986
[TBL] [Abstract][Full Text] [Related]
19. Causes of chronic productive cough: An approach to management.
Martin MJ; Harrison TW
Respir Med; 2015 Sep; 109(9):1105-13. PubMed ID: 26184784
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Fal AM; Schönknecht K
Wiad Lek; 2015; 68(2):139-44. PubMed ID: 26181148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
